Upgrade of uhplc system to a single quadrupole LC MS system
Ended Awarded
- Contract number
- 75F40118F10143
- Awardee
-
Agilent Technologies Inc. UEI SD9JZ9S7MEA6 Part of Agilent Technologies, Inc.
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $207,896
Award facts
- Opportunity
-
- Scientific Equipment and Services Solicitation · Posted Jun 13, 2019
- Contract value 100% obligated
- $207,896.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Marshallton, DE 19808, USA
Award details come from SAM.gov/FPDS.
About this award
The Food and Drug Administration awarded a $207,896.24 delivery order to Agilent Technologies Inc. on July 23, 2018, for the upgrade of an Ultra High Performance Liquid Chromatography (UHPLC) system to a Single Quadrupole Liquid Chromatography-Mass Spectrometry (LC-MS) system. This delivery order, with an ultimate completion date of September 10, 2018, was issued under a firm fixed-price contract structure with no set-aside designation. The work was performed at the FDA's facility in Marshtonlon, Delaware. Agilent Technologies, a global leader in analytical instrumentation headquartered in Santa Clara, California, delivered this advanced analytical equipment through its Customer Service and Sales division, leveraging its extensive experience providing specialized scientific instruments to federal agencies.
This delivery order represents a child contract under Agilent Technologies' broader relationship with federal agencies and demonstrates the company's established role as a premier supplier of mass spectrometry and liquid chromatography systems for government laboratory operations. The LC-MS upgrade enables the FDA to enhance its analytical capabilities for drug testing and quality assurance activities, supporting the agency's mission in ensuring pharmaceutical safety and efficacy. Agilent's selection reflects the company's competitive market position and demonstrated capability in providing sophisticated laboratory instrumentation, as evidenced by its multiple Indefinite Delivery Contracts with federal agencies including the Department of Veterans Affairs and U.S. Army Research, Development and Engineering Command.
Quick answers
Who was awarded contract 75F40118F10143?
75F40118F10143 was awarded to Agilent Technologies Inc. by Food and Drug Administration (Department of Health and Human Services) on July 23, 2018.
How much is contract 75F40118F10143 worth?
The government has obligated $207,896 on 75F40118F10143.
Is contract 75F40118F10143 an order under another contract?
Yes. 75F40118F10143 is a delivery order under GS07F0564X, a federal supply schedule, on Scientific Equipment and Services (FSS-66).
Was contract 75F40118F10143 competed?
The extent of competition for 75F40118F10143 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award